NO20014479D0 - Fremgangsmåte ved behandling av spiseforstyrrelser - Google Patents
Fremgangsmåte ved behandling av spiseforstyrrelserInfo
- Publication number
- NO20014479D0 NO20014479D0 NO20014479A NO20014479A NO20014479D0 NO 20014479 D0 NO20014479 D0 NO 20014479D0 NO 20014479 A NO20014479 A NO 20014479A NO 20014479 A NO20014479 A NO 20014479A NO 20014479 D0 NO20014479 D0 NO 20014479D0
- Authority
- NO
- Norway
- Prior art keywords
- eating disorders
- treating eating
- treating
- nervosa
- snacking
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12515099P | 1999-03-19 | 1999-03-19 | |
PCT/US2000/007115 WO2000054765A1 (en) | 1999-03-19 | 2000-03-17 | Method of treating eating disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20014479D0 true NO20014479D0 (no) | 2001-09-14 |
NO20014479L NO20014479L (no) | 2001-11-02 |
Family
ID=22418412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014479A NO20014479L (no) | 1999-03-19 | 2001-09-14 | Fremgangsmåte ved behandling av spiseforstyrrelser |
Country Status (23)
Country | Link |
---|---|
US (1) | US6365633B1 (no) |
EP (1) | EP1178789B1 (no) |
JP (1) | JP2003519087A (no) |
KR (1) | KR100432825B1 (no) |
CN (1) | CN1188120C (no) |
AT (1) | ATE401066T1 (no) |
AU (1) | AU773188C (no) |
BR (1) | BR0009026A (no) |
CA (1) | CA2367666C (no) |
CZ (1) | CZ20013278A3 (no) |
DE (1) | DE60039508D1 (no) |
ES (1) | ES2307501T3 (no) |
HK (1) | HK1045455B (no) |
HU (1) | HUP0200495A3 (no) |
IL (1) | IL145240A (no) |
MX (1) | MXPA01009404A (no) |
NO (1) | NO20014479L (no) |
NZ (1) | NZ514011A (no) |
PL (1) | PL351963A1 (no) |
SK (1) | SK12992001A3 (no) |
TR (1) | TR200102646T2 (no) |
WO (1) | WO2000054765A1 (no) |
ZA (1) | ZA200107533B (no) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020006963A1 (en) * | 1992-06-23 | 2002-01-17 | Young James W. | Method of using and compositions comprising (-) sibutramine optionally in combination with other pharmacologically active compounds |
US20020006964A1 (en) * | 1995-05-16 | 2002-01-17 | Young James W. | Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds |
US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
WO2002083631A1 (en) | 2001-04-13 | 2002-10-24 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
US7105526B2 (en) | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US20050131074A1 (en) * | 2003-08-04 | 2005-06-16 | Beckman Kristen M. | Methods for treating metabolic syndrome |
CA2551037A1 (en) | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | Novel piperidine derivative |
US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
EP1784390A2 (en) * | 2004-08-13 | 2007-05-16 | Amgen Inc. | Substituted benzofused heterocycles |
US8394765B2 (en) * | 2004-11-01 | 2013-03-12 | Amylin Pharmaceuticals Llc | Methods of treating obesity with two different anti-obesity agents |
ES2325773T5 (es) | 2004-11-01 | 2014-02-24 | Amylin Pharmaceuticals, Llc. | Tratamiento de la obesidad y de los trastornos relacionados |
WO2007022123A2 (en) | 2005-08-11 | 2007-02-22 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides with selectable properties |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
RU2417985C2 (ru) | 2005-05-30 | 2011-05-10 | Баниу Фармасьютикал Ко., Лтд. | Новые производные пиперидина |
US20100216758A1 (en) | 2005-08-10 | 2010-08-26 | Makoto Ando | Pyridone Compounds |
EP2330125A3 (en) | 2005-08-11 | 2012-12-12 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides with selectable properties |
JPWO2007024004A1 (ja) | 2005-08-24 | 2009-03-05 | 萬有製薬株式会社 | フェニルピリドン誘導体 |
EP1939194A4 (en) | 2005-09-07 | 2010-12-08 | Banyu Pharma Co Ltd | AROMATIC SUBSTITUTED BICYLIC PYRIDONE DERIVATIVE |
EP1938811A4 (en) * | 2005-09-22 | 2008-12-17 | Eisai R&D Man Co Ltd | MEDICAL COMPOSITION FOR THE TREATMENT OF BULAMINE AND BULAMIC DEPRESSIONS |
EP1940842B1 (en) | 2005-09-29 | 2012-05-30 | Merck Sharp & Dohme Corp. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
JP2009512715A (ja) | 2005-10-21 | 2009-03-26 | ノバルティス アクチエンゲゼルシャフト | レニン阻害剤と抗異脂肪血症剤および/または抗肥満症剤の組み合わせ |
CA2627139A1 (en) | 2005-10-27 | 2007-05-03 | Banyu Pharmaceutical Co., Ltd. | Novel benzoxathiin derivative |
EP1953165B1 (en) | 2005-11-10 | 2012-02-01 | Msd K.K. | Aza-substituted spiro derivative |
EP2083831B1 (en) | 2006-09-22 | 2013-12-25 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
CA2664358A1 (en) | 2006-09-28 | 2008-04-03 | Banyu Pharmaceutical Co., Ltd. | Diarylketimine derivative |
RU2486902C2 (ru) | 2007-01-16 | 2013-07-10 | АЙПИИНТЛ, ЭлЭлСи | Новая композиция для лечения метаболического синдрома |
EP2145884B1 (en) | 2007-04-02 | 2014-08-06 | Msd K.K. | Indoledione derivative |
EA020466B1 (ru) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EA201070609A1 (ru) * | 2007-11-14 | 2010-12-30 | Амилин Фармасьютикалз, Инк. | Способы лечения ожирения и ассоциированных с ожирением заболеваний и расстройств |
WO2009110510A1 (ja) | 2008-03-06 | 2009-09-11 | 萬有製薬株式会社 | アルキルアミノピリジン誘導体 |
JPWO2009119726A1 (ja) | 2008-03-28 | 2011-07-28 | Msd株式会社 | メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体 |
CA2666036C (en) | 2008-05-16 | 2017-09-12 | Chien-Hung Chen | Novel compositions and methods for treating hyperproliferative diseases |
CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
AU2009261248A1 (en) | 2008-06-19 | 2009-12-23 | Banyu Pharmaceutical Co., Ltd. | Spirodiamine-diarylketoxime derivative |
CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
JPWO2010013595A1 (ja) | 2008-07-30 | 2012-01-12 | Msd株式会社 | 5員−5員又は5員−6員縮環シクロアルキルアミン誘導体 |
CN102264228A (zh) | 2008-10-22 | 2011-11-30 | 默沙东公司 | 用于抗糖尿病药的新的环状苯并咪唑衍生物 |
US8329914B2 (en) | 2008-10-31 | 2012-12-11 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
US20110245209A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
US20110243940A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Bicyclic pyranone derivatives and methods of use thereof |
WO2011106273A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA2826649C (en) | 2011-02-25 | 2016-07-26 | Merck Sharp & Dohme Corp. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
US20140045746A1 (en) | 2012-08-02 | 2014-02-13 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
BR112015019836A2 (pt) | 2013-02-22 | 2017-07-18 | Merck Sharp & Dohme | composto, composição farmacêutica, e, uso de um composto |
US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
CN113388007A (zh) | 2013-06-05 | 2021-09-14 | 博士医疗爱尔兰有限公司 | 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法 |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
EP3186242B1 (en) | 2014-08-29 | 2021-10-06 | Tes Pharma S.r.l. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
EP3526199B1 (en) | 2016-10-14 | 2022-04-13 | Tes Pharma S.r.l. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
EP3558298A4 (en) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | ANTIDIABETIC SPIROCHROMAN COMPOUNDS |
CN113302189A (zh) | 2018-11-20 | 2021-08-24 | Tes制药有限责任公司 | α-氨基-β-羧基己二烯二酸半醛去羧酶的抑制剂 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2675573B2 (ja) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | 脳機能改善剤 |
IE61928B1 (en) * | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
US5356934A (en) * | 1990-03-29 | 1994-10-18 | Eli Lilly And Company | Selected serotonin subtype receptor agonist to treat sleep apnea |
AU744261B2 (en) * | 1997-04-24 | 2002-02-21 | Merck Sharp & Dohme Limited | Use of NK-1 receptor antagonists for treating eating disorders |
US6331571B1 (en) * | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
EP1150672A1 (en) * | 1999-01-20 | 2001-11-07 | Knoll Pharmaceutical Company | Method to aid smoking cessation |
DK1158973T3 (da) * | 1999-02-24 | 2005-05-30 | Univ Cincinnati | Anvendelse af sulfamatderivater til behandling af impulskontrolafvigelser |
-
2000
- 2000-03-17 KR KR10-2001-7011781A patent/KR100432825B1/ko not_active IP Right Cessation
- 2000-03-17 WO PCT/US2000/007115 patent/WO2000054765A1/en active IP Right Grant
- 2000-03-17 AT AT00918073T patent/ATE401066T1/de not_active IP Right Cessation
- 2000-03-17 NZ NZ514011A patent/NZ514011A/en not_active IP Right Cessation
- 2000-03-17 EP EP00918073A patent/EP1178789B1/en not_active Expired - Lifetime
- 2000-03-17 TR TR2001/02646T patent/TR200102646T2/xx unknown
- 2000-03-17 CN CNB008074321A patent/CN1188120C/zh not_active Expired - Fee Related
- 2000-03-17 ES ES00918073T patent/ES2307501T3/es not_active Expired - Lifetime
- 2000-03-17 AU AU38947/00A patent/AU773188C/en not_active Ceased
- 2000-03-17 DE DE60039508T patent/DE60039508D1/de not_active Expired - Lifetime
- 2000-03-17 CZ CZ20013278A patent/CZ20013278A3/cs unknown
- 2000-03-17 PL PL00351963A patent/PL351963A1/xx not_active Application Discontinuation
- 2000-03-17 HU HU0200495A patent/HUP0200495A3/hu unknown
- 2000-03-17 SK SK1299-2001A patent/SK12992001A3/sk unknown
- 2000-03-17 US US09/528,355 patent/US6365633B1/en not_active Expired - Fee Related
- 2000-03-17 JP JP2000604841A patent/JP2003519087A/ja active Pending
- 2000-03-17 MX MXPA01009404A patent/MXPA01009404A/es unknown
- 2000-03-17 IL IL145240A patent/IL145240A/en not_active IP Right Cessation
- 2000-03-17 BR BR0009026-3A patent/BR0009026A/pt not_active Application Discontinuation
- 2000-03-17 CA CA002367666A patent/CA2367666C/en not_active Expired - Fee Related
-
2001
- 2001-09-12 ZA ZA200107533A patent/ZA200107533B/xx unknown
- 2001-09-14 NO NO20014479A patent/NO20014479L/no not_active Application Discontinuation
-
2002
- 2002-07-17 HK HK02105308.4A patent/HK1045455B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1045455B (zh) | 2009-04-09 |
EP1178789A4 (en) | 2004-02-18 |
CZ20013278A3 (cs) | 2002-07-17 |
AU3894700A (en) | 2000-10-04 |
AU773188B2 (en) | 2004-05-20 |
MXPA01009404A (es) | 2004-03-19 |
WO2000054765A8 (en) | 2002-05-23 |
KR100432825B1 (ko) | 2004-05-24 |
IL145240A (en) | 2007-02-11 |
ZA200107533B (en) | 2002-12-12 |
ATE401066T1 (de) | 2008-08-15 |
CA2367666C (en) | 2008-11-25 |
HK1045455A1 (en) | 2002-11-29 |
DE60039508D1 (de) | 2008-08-28 |
CN1188120C (zh) | 2005-02-09 |
CN1365276A (zh) | 2002-08-21 |
TR200102646T2 (tr) | 2002-08-21 |
IL145240A0 (en) | 2002-06-30 |
EP1178789A1 (en) | 2002-02-13 |
AU773188C (en) | 2006-01-05 |
SK12992001A3 (sk) | 2002-03-05 |
KR20020063107A (ko) | 2002-08-01 |
PL351963A1 (en) | 2003-07-14 |
NZ514011A (en) | 2001-09-28 |
ES2307501T3 (es) | 2008-12-01 |
NO20014479L (no) | 2001-11-02 |
US6365633B1 (en) | 2002-04-02 |
CA2367666A1 (en) | 2000-09-21 |
EP1178789B1 (en) | 2008-07-16 |
HUP0200495A3 (en) | 2004-09-28 |
BR0009026A (pt) | 2003-03-05 |
WO2000054765A1 (en) | 2000-09-21 |
JP2003519087A (ja) | 2003-06-17 |
HUP0200495A2 (en) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20014479D0 (no) | Fremgangsmåte ved behandling av spiseforstyrrelser | |
EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
NO308248B1 (no) | Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat | |
WO2002057252A3 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
CZ305838B6 (cs) | N-(2-arylethyl)benzylaminy jako antagonisté receptoru 5-HT6 | |
MXPA03011722A (es) | Derivados de piperidina utiles como moduladores de actividad de quimiocina. | |
WO2003047520A3 (en) | SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS | |
BRPI0407841A (pt) | inibidores heterocìclicos de quinase | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
WO2000056315A8 (en) | Treatment of pain | |
WO2004067703A3 (en) | 5ht7 antagonists and inverse agonists | |
SE0103795D0 (sv) | Compounds and method for the treatment of överactive bladder | |
BG105996A (en) | Method of treating eating disorders | |
NO20063299L (no) | Syntese av en polymorf av 4-amino-5-klor-2-metoksy-N-(1-azabisyklo[3.3.1]non-4-yl)benzamidhydrokloridhydrat | |
MXPA01009461A (es) | Tratamiento de osteoartritis. | |
DK1387837T3 (da) | Hidtil ukendte azol- eller triazolderivater, fremgangsmåden til deres fremstilling og deres anvendelse som antimykotiske lægemidler | |
MXPA01009469A (es) | Tratamiento para disminuir la adhesividad de las plaquetas. | |
MXPA01009468A (es) | Tratamiento de hipertension pulmonar. | |
FI942798A (fi) | Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja niiden käyttö | |
MXPA04004071A (es) | Metodo para tratamiento de vejiga hiperactiva. | |
MXPA01009463A (es) | Tratamiento de hernia hiatial. | |
MXPA01009465A (es) | Perdida de peso despues del embarazo. | |
ATE319452T1 (de) | Arzneimittel gegen essstörungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |